Read articles from Global
April 01, 2026 by gfn.events
GFN26 Keynote announcement: ‘The Impact of Prohibition on Health and Ethics’
The GFN26 team has announced that the Global Forum on Nicotine’s online conference programme is now live. A keynote session will take place on Thursday, 4 June 2026 at 09:30 in the main auditorium, where Dr Garrett McGovern, Professor Jean-François Etter and Dr Arielle Selya will discuss the impact of prohibition on health and ethics. Registration is now open, with further details available on the official website.
April 01, 2026 by blogspot.com
The Rest of the Story: Tobacco and Alcohol News Analysis and Commentary: A New Generation of Youth are NOT Getting Addicted to Nicotine Through Vaping
Growing concern is being raised about a new generation of young people developing nicotine dependence through emerging products such as e-cigarettes and nicotine pouches. Critics argue that these products, often marketed as safer alternatives, may still contribute to addiction among adolescents and young adults. The discussion highlights how early exposure to nicotine increases the risk of long-term dependence, particularly given the vulnerability of the developing brain. At the same time, rising use of newer nicotine formats among youth is fuelling debate over whether current public health strategies are adequately addressing changing patterns of consumption. The issue reflects broader concerns that progress in reducing smoking rates could be offset by the growth of alternative nicotine products.
March 31, 2026 by sciencemediacentre.org
expert reaction to systematic review of ecigs for stopping smoking
Growing attention is being given to a major systematic review assessing the effectiveness of e-cigarettes in helping smokers quit. Expert reactions highlight that the findings are consistent with earlier high-quality evidence, suggesting that nicotine e-cigarettes can be an effective cessation tool. Despite this, some scientists point out that these results are still not fully reflected in public health debates, where scepticism towards vaping remains widespread. The discussion underscores a broader disconnect between emerging scientific evidence and how it is interpreted or communicated in policy and public discourse. At its core, the issue raises questions about whether current perceptions of vaping align with the weight of existing research.
March 31, 2026 by thefirebreak.org
Time to Redefine Conflict of Interest
Growing scrutiny is being placed on how conflicts of interest are defined and managed within public policy, research, and advocacy. Concerns are emerging that current frameworks may be too narrow, overlooking indirect influences such as funding sources, institutional ties, and ideological alignment. Critics argue that this lack of clarity can distort policy debates and undermine trust in decision-making processes. The discussion calls for a broader and more transparent approach to identifying potential biases, particularly in areas where science, regulation, and public interest intersect. At its core, the issue raises fundamental questions about accountability, credibility, and the integrity of evidence used to shape policy.
March 30, 2026 by umass.edu
Nicotine E-cigarettes More Successful in Helping Smokers Quit
Growing evidence is strengthening the case for nicotine e-cigarettes as an effective smoking cessation tool. A comprehensive review of global research indicates that these products consistently outperform traditional methods such as nicotine patches, gum, and behavioural support. Higher-quality studies show that quit rates among users of nicotine e-cigarettes can be around 20% to 40% higher compared to conventional nicotine replacement therapies. The findings suggest that both the delivery of nicotine and the behavioural aspects of vaping may play a role in supporting smokers attempting to quit. At the same time, important gaps remain, particularly regarding long-term safety and comparisons with certain medications. The growing body of evidence is contributing to an ongoing debate about how e-cigarettes should be integrated into public health strategies aimed at reducing smoking-related harm.
March 30, 2026 by neurosciencenews.com
Nicotine Vapes Outperform Patches and Gum for Quitters
A new overview of 14 systematic reviews suggests that nicotine e-cigarettes are more effective for smoking cessation than traditional methods. The study highlights gaps in comparing e-cigarettes to newer aids and the need for global research on long-term safety. While e-cigarettes are effective for quitting, evidence on adverse events is inconclusive. The overview emphasizes the importance of high-quality data and urgent studies in low-income countries. Funding was provided by Cancer Research UK. The lead author stresses the consistent effectiveness of e-cigarettes in helping people quit smoking, despite mixed claims based on lower-quality reviews. The research aims to clarify the role of e-cigarettes in smoking cessation.
March 27, 2026 by gfn.tv
SCIENCE OF VAPING #9 | WHY LAB TESTS GET VAPING WRONG?
In this episode of the Science Series, Roberto Sussman breaks down why many lab studies on e‑cigarette emissions can’t be trusted—and how bad testing setups can create misleading “high toxin” results. He explains the “optimal regime” for vaping devices (power, resistance, airflow), why reproducibility requires full reporting of test conditions, and how unrealistic puffing machines can cause overheating and artificially inflate byproducts.
March 27, 2026 by medicalxpress.com
Nicotine e-cigarettes found to be more successful in helping smokers quit
Nicotine e-cigarettes are found to help adults quit smoking more effectively than other methods, with quit rates up to 40% higher. A review of 14 systematic reviews across nearly a decade of studies showed consistent evidence towards this conclusion. While acknowledging the health risks of vaping, researchers emphasize its lesser harm compared to smoking and highlight concerns about youth uptake. The effectiveness of e-cigarettes may be related to factors beyond nicotine delivery, and further studies are needed to compare them to prescription drugs. The study aims to clarify misconceptions about vaping and stresses the importance of evidence amid public perception challenges.
March 27, 2026 by medicalxpress.com
Nicotine e-cigarettes found to be more successful in helping smokers quit
Nicotine e-cigarettes are found to help adults quit smoking more effectively than other methods, with quit rates up to 40% higher. A review of 14 systematic reviews across nearly a decade of studies showed consistent evidence towards this conclusion. While acknowledging the health risks of vaping, researchers emphasize its lesser harm compared to smoking and highlight concerns about youth uptake. The effectiveness of e-cigarettes may be related to factors beyond nicotine delivery, and further studies are needed to compare them to prescription drugs. The study aims to clarify misconceptions about vaping and stresses the importance of evidence amid public perception challenges.
March 27, 2026 by medicalxpress.com
Nicotine e-cigarettes found to be more successful in helping smokers quit
Growing scientific consensus is emerging around the role of nicotine e-cigarettes in helping people quit smoking. A large-scale review of existing evidence shows consistent findings across multiple studies, indicating that these products can significantly improve quit rates compared to traditional methods. Nicotine e-cigarettes have been associated with cessation success rates approximately 20% to 40% higher than those achieved with conventional nicotine replacement therapies such as patches or gum. Their effectiveness may be linked not only to nicotine delivery but also to behavioural and sensory aspects that mimic smoking, making the transition easier for many users. At the same time, uncertainties remain, particularly regarding long-term health effects and comparisons with certain prescription medications used for smoking cessation. The findings contribute to an ongoing debate about how e-cigarettes should be positioned within public health strategies aimed at reducing smoking-related harm.